These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28440083)

  • 1. Systems Metabolomics for Prediction of Metabolic Syndrome.
    Pujos-Guillot E; Brandolini M; Pétéra M; Grissa D; Joly C; Lyan B; Herquelot É; Czernichow S; Zins M; Goldberg M; Comte B
    J Proteome Res; 2017 Jun; 16(6):2262-2272. PubMed ID: 28440083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants.
    Wu Q; Li J; Sun X; He D; Cheng Z; Li J; Zhang X; Xie Y; Zhu Y; Lai M
    EBioMedicine; 2021 Dec; 74():103707. PubMed ID: 34801968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
    Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
    Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular signature for the metabolic syndrome by urine metabolomics.
    Bruzzone C; Gil-Redondo R; Seco M; Barragán R; de la Cruz L; Cannet C; Schäfer H; Fang F; Diercks T; Bizkarguenaga M; González-Valle B; Laín A; Sanz-Parra A; Coltell O; de Letona AL; Spraul M; Lu SC; Buguianesi E; Embade N; Anstee QM; Corella D; Mato JM; Millet O
    Cardiovasc Diabetol; 2021 Jul; 20(1):155. PubMed ID: 34320987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplatform metabolomics for an integrative exploration of metabolic syndrome in older men.
    Comte B; Monnerie S; Brandolini-Bunlon M; Canlet C; Castelli F; Chu-Van E; Colsch B; Fenaille F; Joly C; Jourdan F; Lenuzza N; Lyan B; Martin JF; Migné C; Morais JA; Pétéra M; Poupin N; Vinson F; Thevenot E; Junot C; Gaudreau P; Pujos-Guillot E
    EBioMedicine; 2021 Jul; 69():103440. PubMed ID: 34161887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.
    Blasco H; Błaszczyński J; Billaut JC; Nadal-Desbarats L; Pradat PF; Devos D; Moreau C; Andres CR; Emond P; Corcia P; Słowiński R
    J Biomed Inform; 2015 Feb; 53():291-9. PubMed ID: 25499899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Metabolomic Profiles Associated With Untreated Metabolic Syndrome Patients in the Chinese Population.
    Li Y; Wang Y; Zhuang Y; Zhang P; Chen S; Asakawa T; Gao B
    Clin Transl Sci; 2020 Nov; 13(6):1271-1278. PubMed ID: 32543029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
    Gong LL; Yang S; Zhang W; Han FF; Lv YL; Xuan LL; Liu H; Liu LH
    J Pharm Biomed Anal; 2020 Jan; 177():112848. PubMed ID: 31479998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Pre-frailty Sub-Phenotypes in Elderly Using Metabolomics.
    Pujos-Guillot E; Pétéra M; Jacquemin J; Centeno D; Lyan B; Montoliu I; Madej D; Pietruszka B; Fabbri C; Santoro A; Brzozowska A; Franceschi C; Comte B
    Front Physiol; 2018; 9():1903. PubMed ID: 30733683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory lipidomics in patients with nascent Metabolic Syndrome.
    Ramakrishanan N; Denna T; Devaraj S; Adams-Huet B; Jialal I
    J Diabetes Complications; 2018 Aug; 32(8):791-794. PubMed ID: 29895440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Metabolomics for Plasma Amino Acids and Carnitines in Patients with Metabolic Syndrome Using HPLC-MS/MS.
    Gong LL; Yang S; Zhang W; Han FF; Xuan LL; Lv YL; Liu H; Liu LH
    Dis Markers; 2020; 2020():8842320. PubMed ID: 32733621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic and Lipidomic Signatures of Metabolic Syndrome and its Physiological Components in Adults: A Systematic Review.
    Monnerie S; Comte B; Ziegler D; Morais JA; Pujos-Guillot E; Gaudreau P
    Sci Rep; 2020 Jan; 10(1):669. PubMed ID: 31959772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolomics: an overview of its usefulness and future potential in prenatal diagnosis.
    Parfieniuk E; Zbucka-Kretowska M; Ciborowski M; Kretowski A; Barbas C
    Expert Rev Proteomics; 2018 Oct; 15(10):809-816. PubMed ID: 30239246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.
    Sookoian S; Pirola CJ
    World J Gastroenterol; 2015 Jan; 21(3):711-25. PubMed ID: 25624707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A metabolomics-driven approach to predict cocoa product consumption by designing a multimetabolite biomarker model in free-living subjects from the PREDIMED study.
    Garcia-Aloy M; Llorach R; Urpi-Sarda M; Jáuregui O; Corella D; Ruiz-Canela M; Salas-Salvadó J; Fitó M; Ros E; Estruch R; Andres-Lacueva C
    Mol Nutr Food Res; 2015 Feb; 59(2):212-20. PubMed ID: 25298021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems medicine and metabolic modelling.
    Mardinoglu A; Nielsen J
    J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of metabolomics for the identification and validation of clinical biomarkers for preterm birth: Preterm SAMBA.
    Cecatti JG; Souza RT; Sulek K; Costa ML; Kenny LC; McCowan LM; Pacagnella RC; Villas-Boas SG; Mayrink J; Passini R; Franchini KG; Baker PN;
    BMC Pregnancy Childbirth; 2016 Aug; 16(1):212. PubMed ID: 27503110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum.
    Zhang X; Xu L; Shen J; Cao B; Cheng T; Zhao T; Liu X; Zhang H
    Biochim Biophys Acta; 2013 Aug; 1832(8):1207-16. PubMed ID: 23524237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
    Lindahl A; Forshed J; Nordström A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.